Data gathered: September 10
Alternative Data for Mind Medicine (MindMed)
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 4 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 14,000 | Sign up | Sign up | Sign up |
| Employee Rating | 92 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 39 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 6,803 | Sign up | Sign up | Sign up |
| Instagram Followers | 19,226 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 60 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 25,781 | Sign up | Sign up | Sign up |
| Twitter Followers | 23,876 | Sign up | Sign up | Sign up |
| Twitter Mentions | 86 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 87 | Sign up | Sign up | Sign up |
| Linkedin Employees | N/A | Sign up | Sign up | Sign up |
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness.
| Price | $9.77 |
| Target Price | Sign up |
| Volume | 845,210 |
| Market Cap | $714M |
| Year Range | $4.89 - $10.19 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Drug Manufacturers |
In the news
-inc-logo-1200x675.jpg?v=20240515130629&w=240&h=240&zc=2){kind=logo} |
Invesco Ltd. Sells 2,300 Shares of Mind Medicine (MindMed) Inc. $MNMDSeptember 8 - ETF Daily News |
 |
Mind Medicine (MindMed) Inc. (MNMD)’s MM120 Earns FDA Breakthrough Status in Anxiety TreatmentSeptember 1 - Yahoo |
|
Swiss National Bank Has $624,000 Stock Holdings in Mind Medicine (MindMed) Inc. $MNMDAugust 27 - ETF Daily News |
|
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Rating of “Buy” from AnalystsAugust 22 - ETF Daily News |
|
Blair William & Co. IL Takes $73,000 Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD)August 14 - ETF Daily News |
|
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have TodayAugust 11 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 0 | 0 | 0 | -43M | -41M | -0.500 |
| Q1 '25 | 0 | 0 | 0 | -23M | -23M | -0.350 |
| Q4 '24 | 0 | 0 | 0 | -35M | -34M | -0.410 |
| Q3 '24 | 0 | 0 | 0 | -14M | -13M | -0.270 |
| Q2 '24 | 0 | 0 | 0 | -5.9M | -5.4M | -0.260 |
Insider Transactions View All
| Karlin Daniel filed to sell 438,329 shares at $6.8. June 26 '25 |
| Barrow Robert filed to sell 830,065 shares at $6.8. June 26 '25 |
| Sullivan Mark filed to sell 305,130 shares at $6.8. June 26 '25 |
| Liao Carrie filed to sell 144,923 shares at $6.7. March 26 '25 |
| Sullivan Mark filed to sell 316,621 shares at $6.7. March 26 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$176.96 0% | 44 |
 |
Eli Lilly and CompanyLLY |
$750.61 0% | 72 |
 |
PfizerPFE |
$24.71 0% | 54 |
 |
AstrazenecaAZN |
$81.22 0% | 55 |
 |
AbbVieABBV |
$210.42 0% | 55 |
Read more about Mind Medicine (MindMed) (MNMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Mind Medicine (MindMed)?
The Market Cap of Mind Medicine (MindMed) is $714M.
What is the current stock price of Mind Medicine (MindMed)?
Currently, the price of one share of Mind Medicine (MindMed) stock is $9.77.
How can I analyze the MNMD stock price chart for investment decisions?
The MNMD stock price chart above provides a comprehensive visual representation of Mind Medicine (MindMed)'s stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Mind Medicine (MindMed) shares. Our platform offers an up-to-date MNMD stock price chart, along with technical data analysis and alternative data insights.
Does MNMD offer dividends to its shareholders?
As of our latest update, Mind Medicine (MindMed) (MNMD) does not offer dividends to its shareholders. Investors interested in Mind Medicine (MindMed) should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Mind Medicine (MindMed)?
Some of the similar stocks of Mind Medicine (MindMed) are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.